3-Dimensional Pharmaceuticals, Inc. - Feb., p. 39
3M Pharmaceuticals - Mar., p. 66
Abbott Laboratories - Mar., p. 67, 75; Apr., p. 105; Oct., p. 300; Nov., p. 331; Dec., p. 359
Advanced Viral Research Corp. - Mar., p. 73
Affymetrix, Inc. - Apr., p. 104
Agouron Pharmaceuticals, Inc. - Feb., p. 33, 37, 39; Mar., p. 65, 75; Apr., p. 103; May, p. 140; July, p. 200; Aug., p. 234
AgraCetus Inc. - Feb., p. 40; Nov., p. 330
AIDS Drug Assistance Program - Apr., p. 105
AIDS Healthcare Foundation - Dec., p. 363
AIDS ReSEARCH Alliance - May, p. 136; Sep., p. 263; Nov., p. 333
AIDS Research and Reference Reagent Program, NIH - Mar., p. 77
AIDS Research Program, Univ. of California - June, p. 170
AIDS Vaccine Advocacy Coalition - Mar., p. 72
AIDS Vaccine Evaluation Group (AVEG) - May, p. 138
AIDS Vaccine Research Committee, NIH - Mar., p. 76
Allelix Biopharmaceuticals Inc. - Feb., p. 38
Alpha 1 Biomedicals Inc. - June, p. 172
Alpha Therapeutic Corp. - Mar., p. 76
Altana AG - Aug., p. 236
Alternate Site Distributors, Inc. - June, p. 170
Amarillo Biosciences, Inc. - Aug., p. 236, 239; Sep., p. 265; Nov., p. 326
American Home Products Corp. - Apr., p. 104
American Pharmaceutical Partners - July, p. 202
American Red Cross - June, p. 168; Nov., p. 328
American Viewpoint for AIDS Action - May, p. 139
Amgen Corp. - Aug., p. 239; Oct., p. 289
AMRAD Corp. - Aug., p. 236; Sep., p. 269
Andrulis Pharmaceuticals Corp. - Mar., p. 71
Animal Liberation Front - Dec., p. 363
Apothecus Pharmaceutical Corp. - Apr., p. 104
Aquila Biopharmaceuticals, Inc. - May, p. 139
Arkopharma Labs. - Mar., p. 76
Aronex Pharmaceuticals, Inc. - Oct., p. 299
ArQule, Inc. - July, p. 202; Oct., p. 298; Nov., p. 333
Arris Pharmaceutical Corp. - Dec., p. 367
Astra USA, Inc. - Mar., p. 67; Oct., p. 298
Auragen, Inc. - Feb., p. 40
Australian Institute of Mucosal Immunology - Sep., p. 267
Avid Corp. - July, p. 198
Aviron, Inc. - Mar., p. 74; May, p. 137; July, p. 193; Dec., p. 361
Bausch & Lomb - Nov., p. 329
Baxter International Inc. - Feb., p. 43
Baylor Univ. Medical Center - July, p. 200; Sep., p. 266
BC Center for Excellence in HIV/AIDS - Nov., p. 332
Beaufour Ipsen - Sep., p. 269
Bedford Pharmaceutical - Apr., p. 105
Bergen Brunswig Corp. - June, p. 170
Berlex Laboratories, Inc. - June, p. 166
BioChem Pharma Inc. - Apr., p. 99; May, p. 132; June, p. 162; Aug., p. 233, 234; Nov., p. 334; Dec., p. 363
BioCryst Pharmaceuticals, Inc. - May, p. 136
BioDelivery Sciences, Inc. - Apr., p. 104
Biogen, Inc. - Apr., p. 107; May, p. 142; Aug., p. 239
Biomolecular Research Institute - Oct., p. 300
BioStratum, Inc. - Dec., p. 353
Biota Holdings Ltd. - Oct., p. 292, 300
Biotechnology Information Institute - Feb., p. 45; Nov., p. 335
BioVector Therapeutics SA - May, p. 132
Boehringer Ingelheim Pharmaceuticals, Inc. - Feb., p. 42; Apr., p. 105; May, p. 138; Aug., p. 234; Oct., p. 296; Dec., p. 359, 362
Boehringer Mannheim GmbH - June, p. 164
Bristol-Myers Squibb Co. - Feb., p. 41, 44; Mar., p. 71; Apr., p. 101; June, p. 174; Aug., p. 234; Sep., p. 260, 269; Oct., p. 295, 298, 300; Nov., p. 328; Dec., p. 367
Cangene Corp. - Nov., p. 331, 332
Cantab Pharmaceuticals PLC - Apr., p. 107; Dec., p. 364
CEL-SCI Corp. - Feb., p. 43; May, p. 136; July, p. 204; Sep., p. 263; Oct., p. 298
Celgene Corp. - Mar., p. 71
Cell Genesys, Inc. - Feb., p. 46; Mar., p. 75
Center for Blood Research, Harvard Univ. - Dec., p. 363
Centers for Disease Control and Prevention (CDC) - May, p. 137; Aug., p. 230, 235; Sep., p. 268; Oct., p. 299; Dec., p. 357
Centocor Inc. - Mar., p. 71
Centre for Genetic Engineering and Biotech. (Cuba) - Sep., p. 167
Centre National de la Recherche Scientifique (CNRS) - Dec., p. 364
Cervida Corp. Ltd. - Mar., p. 70
Childrens Hospital Los Angeles - Feb., p. 38
China, Peoples Republic of - Aug., p. 234
Chiron Behring GmbH & Co. - Nov., p. 323
Chiron Corp. - Feb., p. 38; Mar., p. 73; Apr., p. 100; May, p. 138; Sep., p. 269, 271; Nov., p. 323; Dec., p. 367
Chiron Vision Corp. - June, p. 168; Oct., p. 294; Nov., p. 329
Ciba Vision Corp. - July, p. 200
Ciba-Geigy AG (see also Novartis) - June, p. 174; Aug., p. 229
CIRA Technologies, Inc. - June, p. 167
City of Hope National Medical Center - Feb., p. 38
Classsen Immunotherapies - Nov., p. 331
Corange Ltd. - June, p. 164
Corixa Corp. - Mar., p. 78
Cortecs International - Sep., p. 267
Corvas International, Inc. - June, p. 164
CyberChemics Inc. - May, p. 137
Cytel Corp. - Feb., p. 40
CytRx Corp. - Feb., p. 39
Dimethaid Research Inc. - Sep., p. 261
Direct Access Diagnostics - July, p. 197
DowElanco - Nov., p. 336
Dr. Karl Thomae GmbH - Dec., p. 359
Dr. Rentschler Biotechnologie GmbH - May, p. 142
DuPont Merck Pharmaceutical Co. - Feb., p. 38; June, p. 165; Aug., p. 234; Sep., p. 258
East West Herbs Ltd. - Mar., p. 72
EntreMed Inc. - Mar., p. 71
Enzon, Inc. - Sep., p. 267
ESI Lederle - Apr., p. 105
Evans Medical, Ltd. - May, p. 137; Oct., p. 301
Faulding Pharmaceutical Co. - Apr., p. 105
Flamel Technologies S.A. - Feb., p. 35
Food and Drug Administration (FDA) - May, p. 140; June, p. 171, 172; Aug., p. 227; Sep., p. 259
General Injectables & Vaccines Inc. - Nov., p. 323
Genesys Pharma Inc. - June, p. 165
Geniva, Inc. - Feb., p. 40, 46; Nov., p. 330
GenPharm International, Inc. - Feb., p. 46; Mar., p. 75
George Washington Univ. - June, p. 166
Gilead Sciences, Inc. - Feb., p. 40, 42, 43; Mar., p. 73; May, p. 133, 136, 138, 140; July, p. 203; Oct., p. 294; Dec., p. 366
Glaxo Wellcome Inc./PLC - Feb., p. 37, 44; Apr., p. 99, 102, 104, 107; May, p. 141; June, p. 162; July, p. 199, 202, 203, 204; Aug., p. 231, 233, 234; Oct., p. 291, 292, 297, 298, 300; Nov., p. 325, 326, 332, 333
Green Cross Corp. - Mar., p. 73
Hagahai tribe - Apr., p. 106
Harvard Medical School - Aug., p. 236; Dec., p. 353, 363
Hawaii Biotechnology Group, Inc. - Feb., p. 46
Hayashibara Biochemical Laboratories Inc. - Aug., p. 236; Sep., p. 265; Nov., p. 326
Health Care Financing Administration (HCFA) - Dec., p. 366
Health Connection, Ltd. - Mar., p. 76
HemaSure Inc. - Sep., p. 266
HemispheRx Biopharma, Inc. - Feb., p. 39; Mar., p. 74; May, p. 141; Aug., p. 232; Sep., p. 269
Henderson Morley Ltd. - Oct., p. 301
Henry J. Kaiser Family Foundation - July, p. 196
Herpesvirus Diagnostics, Inc. - Dec., p. 358
Hoffmann-La Roche Inc./Ltd. - Feb., p. 39, 41, 42, 43, 46; Mar., p. 67; May, p. 132, 135, 141; June, p. 161, 164, 168; July, p. 198, 200, 203; Aug., p. 239; Sep., p. 260, 265; Oct., p. 294, 296; Nov., p. 324, 326, 329, 333
Home Access Health Corp. - July, p. 197
Houghton Pharmaceuticals, Inc. - July, p. 204
Hubriphar SPRL - July, p. 201
Hybridon, Inc. - Feb., p. 41; Mar., p. 69; May, p. 130, 134, 135; Aug., p. 226; Sep., p. 264, 265
ICN Pharmaceuticals, Inc. - Sep., p. 263; Nov., p. 324; Dec., p. 365
Igen International Inc. - Feb., p. 46
Immune Response Corp. - May, p. 134
Immunex Corp. - May, p. 136
Immuno International AG - Feb., p. 43
IMS America, Inc. - Nov., p. 332
Innogenetics NV - June, p. 170
Innovir Laboratories, Inc. - Feb., p. 39
Institut Curie - Dec., p. 364
Institut Pasteur - Sep., p. 266
Institute for Clinical & Molecular Virology - Sep., p. 266
Institute of Bioorganic Chemistry - May, p. 138
Institute of Cancer Research - Nov., p. 325
Institute of Human Virology - May, p. 134
Institute of Immunology - May, p. 138
Interferon Sciences, Inc. - June, p. 168, 170
International AIDS SocietyÐUSA - July, p. 196
International AIDS Vaccine Initiative - Mar., p. 72
International Association of Physicians in AIDS Care (IAPAC) - Aug., p. 227 Dec., p. 353
International Murex Technologies Corp. - June, p. 170
Isis Pharmaceuticals, Inc. - Feb., p. 40; June, p. 163; July, p. 200
IVAX Corp. - Apr., p. 105
Janssen Pharmaceutica N.V. - Nov., p. 326
Japan Tobacco Inc. - Feb., p. 39; July, p. 200
Jefferson Medical College - Sep., p. 268
Johnson & Johnson Co. - July, p. 197
Joint United Nations Programme on HIV/AIDS - Nov., p. 326
King Pharmaceuticals, Inc. - May, p. 137
Kissei Pharmaceutical Co., Ltd. - July, p. 202; Oct., p. 298
KS Biomedix Holdings PLC - Sep., p. 266
LDS Hospital - Nov., p. 331
Lek Pharmaceutical - Apr., p. 105
Lemmon Pharmaceutical - Apr., p. 105
Lidak Pharmaceuticals Inc. - Mar., p. 75; Apr., p. 105; Aug., p. 225
Lilly & Co., Eli - June, p. 164
Louisiana State Univ. Medical Center - Mar., p. 70
LXR Biotechnology Inc. - June, p. 165
Macfarlane Burnet Centre - Dec., p. 353
Matrix Pharmaceutical Inc. - Mar., p. 76; Aug., p. 236; Sep., p. 259
Max Planck Institute for Molecular Physiology - Aug., p. 233
Maxim Pharmaceuticals, Inc. - July, p. 201
McGill Univ. - Sep., p. 265
Medeva PLC - Feb., p. 39; May, p. 137; Oct., p. 301; Dec., p. 355
Medical Research Council - Aug., p. 229
MediChem Research, Inc. - May, p. 133; June, p. 169; Nov., p. 334
Medicorp Inc. - Feb., p. 45
MedImmune, Inc. - Feb., p. 37; Mar., p. 68, 73; Apr., p. 103; June, p. 167; July, p. 195, 206; Aug., p. 236; Dec., p. 359
Merck & Co., Inc. - Feb., p. 35, 39; Apr., p. 104; May, p. 142; June, p. 167; July, p. 199, 203; Aug., p. 228; Oct., p. 292; Nov., p. 335; Dec., p. 360
Michigan Biologic Products Institute - July, p. 206
MiniMed Inc. - July, p. 204
Mitsubishi Chemical Corp. - Apr., p. 107
Mochida Pharmaceutical Co. - Nov., p. 326
Monarch Pharmaceuticals, Inc. - May, p. 137
Montagnier, L. - June, p. 169
MorphoSys GmbH - Sep., p. 266
Mutchnick, Dr. M. - June, p. 172
Mycogen Corp. - Nov., p. 336
Nabi - Mar., p. 75; Apr., p. 102; Aug., p. 228; Nov., p. 331; Dec., p. 362
NanoSystems LLC - Feb., p. 39
NaPro BioTherapeutics Inc. - Sep., p. 269
Nastech Pharmaceutical Co., Inc. - May, p. 140
Nation of Islam - Aug., p. 236
National Cancer Inst. (NCI) - Mar., p. 73; June, p. 169; Aug., p. 231
National Eye Institute (NEI) - June, p. 168
National Genetics Institute - June, p. 170; Oct., p. 300
National Institute of Allergy and Infectious Diseases (NIAID) - Feb., p. 45; Mar., p. 74, 76; Apr., p. 100; May, p. 132; June, p. 166, 169; July, p. 193; Aug., p. 236; Sep., p. 264, 265; Dec., p. 358
National Institutes of Health (NIH) - Feb., p. 46; Mar., p. 68; Apr., p. 102, 103, 106; Aug., p. 238
National Library of Medicine (NLM) - June, p. 173
Neoprobe Corp. - June, p. 167
New York University Medical Center - Aug., p. 231
New Zealand - Oct., p. 299
NeXstar Pharmaceuticals Inc. - June, p. 164
Northeastern Ohio Universities College of Medicine - Oct., p. 298
Novartis Pharma AG - June, p. 174; July, p. 200
Novopharm Biotech Inc./Novopharm Inc. - Apr., p. 105; June, p. 165
Oclassen Pharmaceuticals, Inc. - Apr., p. 106
Office of AIDS Research, NIH - Nov., p. 335
Office of National AIDS Policy - Feb., p. 44
OraVax, Inc. - Apr., p. 100; Oct., p. 301; Nov., p. 329
Organon Teknika N.V. - Nov., p. 326
Oxford BioSciences Ltd. - Feb., p. 40
Oxo Chemie AG - Sep., p. 261
Paracelsian, Inc. - Mar., p. 72; June, p. 172
Parexel - Feb., p. 35
Pasteur Merieux Connaught - Mar., p. 78; Apr., p. 104, 106; May, p. 138; Sep., p. 262; Nov., p. 329
Pediatric Pharmaceuticals Inc. - Mar., p. 71
Pharma Pacific Management, Pty., Ltd. - Aug., p. 236
Pharmacia & Upjohn, Inc. - Apr., p. 97; May, p. 136
Phylomed Corp. - Mar., p. 75
Point Therapeutics - Dec., p. 365
PowderJect Vaccines, Inc. - Feb., p. 40, 46; Nov., p. 330
Procept, Inc. - May, p. 139; July, p. 203
Protein Design Labs, Inc. - June, p. 164; July, p. 198, 206
Protein Sciences Corp. - May, p. 134
Purdue Univ. - Nov., p. 329
PurePulse Technologies, Inc. - Nov., p. 334
Quidel Corp. - Oct., p. 300
Receptor Biology, Inc. - Sep., p. 266
Research Found. for Microbial Diseases of Osaka Univ. - May, p. 142
RiboGene, Inc. - June, p. 169; July, p. 204; Oct., p. 298
Ribonetics GmbH - Feb., p. 39
RiboTargets Ltd. - Aug., p. 229
Ribozyme Pharmaceuticals, Inc. - Feb., p. 38; June, p. 166
Robert Koch-Institut - June, p. 171
Roche Molecular Systems, Inc. - Feb., p. 46; Aug., p. 230
Rural Advancement Foundation International (RAFI) - Apr., p. 106
Russia - May, p. 138
Salick Family Center for Molecular and Cellular Biology - June, p. 169
Sarawak MediChem Pharmaceuticals, Inc. - May, p. 133
Savage Laboratories - Aug., p. 236
Schering AG - Apr., p. 107; May, p. 142; June, p. 166
Schering-Plough Corp. - Apr., p. 106; June, p. 164, 165; Sep., p. 263; Oct., p. 298; Nov., p. 324; Dec., p. 365
Schering-Plough K.K. - Nov., p. 333
Schwarz Pharma AG - May, p. 139
SciClone Pharmaceuticals Inc. - Sep., p. 271; Nov., p. 333
Scott-Levin - July, p. 203
Scottish National Blood Transfusion Service - Nov., p. 328
Securities and Exchange Commission (SEC) - June, p. 172
Seloc AG - May, p. 139
Sequus Pharmaceuticals Inc. - May, p. 134
Shaman Pharmaceuticals, Inc. - May, p. 135
Shanghai Xiong-Qi Biological Products Co. - Nov., p. 333
Sheffield Medical Technologies Inc. - July, p. 202
Shire Pharmaceuticals Group PLC - Nov., p. 333
Sicor SA - May, p. 139
Small Business Administration - Nov., p. 334
SmithKline Beecham Biologicals - Apr., p. 108; Aug., p. 235; Dec., p. 361
SmithKline Beecham Corp./PLC - May, p. 129, 131, 137, 142; June, p. 166; July, p. 205; Aug., p. 229; Sep., p. 257; Oct., p. 295
Somatix Therapy Corp. - Mar., p. 75
St. Louis Univ. - Oct., p. 301
Steroidogenesis Inhibitors, Inc. - Feb., p. 42
Structural Bioinformatics Inc. - May, p. 137; Aug., p. 233
Swiss Serum and Vaccine Institut - Sep., p. 264
SyStemix, Inc. - Dec., p. 365
Thailand Ministry of Public Health - Sep., p. 261
Therion Biologics Corp. - July, p. 201; Dec., p. 353
Thorne & Co. - May, p. 139
Treasury International, Inc. - Mar., p. 75
Trega Biosciences, Inc. - July, p. 204
Triangle Pharmaceuticals, Inc. - Feb., p. 43; Apr., p. 107; July, p. 198; Oct., p. 299
Trimeris, Inc. - July, p. 204
Tufts Univ. School of Medicine - Dec., p. 365
UNAIDS HIV Drug Access Initiative - Nov., p. 326
Univ. of Birmingham - Oct., p. 301
Univ. of California - June, p. 170; July, p. 202; Sep., p. 268
Univ. of Southern California - Sep., p. 268
Univ. of Turin - May, p. 138
Univ. of Wisconsin Medical School - Apr., p. 101
U.S. Army - Sep., p. 271
U.S. Conference on AIDS - Nov., p. 330
U.S. Department of Health and Human Services - July, p. 196
U.S., President Clinton - June, p. 163
Vaxcel, Inc. - Feb., p. 39
VaxGen, Inc. - July, p. 201
Vertex Pharmaceuticals Inc. - June, p. 164 July, p. 202 Oct., p. 297, 298
Vical, Inc. - Aug., p. 228; Nov., p. 335
VIMRx Pharmaceuticals Inc. - Feb., p. 39
VION Pharmaceuticals Inc. - Sep., p. 271
Viragen, Inc. - June, p. 168; Nov., p. 328
Virco N.V. - Nov., p. 326
Viridae Clinical Sciences, Inc. - Oct., p. 295
Virologix Corp. - Aug., p. 238
ViroPharma Inc. - Feb., p. 39; May, p. 139; July, p. 201; Nov., p. 333
Virus Research Institute, Inc. - Mar., p. 70; Apr., p. 104; July, p. 201; Nov., p. 329
Visible Genetics Inc. - Oct., p. 299
VivoRx Pharmaceuticals Inc. - July, p. 202
W.R. Grace & Co. - Feb., p. 40; Nov., p. 330
Wake Forest Univ. - Dec., p. 360
Walter Reed Army Institute of Research (WRAIR) - Mar., p. 75
Warner-Lambert Co. - Apr., p. 102
Washington Univ. - Aug., p. 227; Nov., p. 336
Watson Pharmaceuticals Inc. - Apr., p. 106
Wayne State Univ. - Sep., p. 271
World Health Organization (WHO) - Aug., p. 230
Wyeth-Lederle Vaccines and Pediatrics - Apr., p. 104; June, p. 173
Yale Univ. - Sep., p. 261, 271
Zenith Goldline - Apr., p. 105
Zynaxis Inc. - Feb., p. 39